TY - JOUR
T1 - Reverse merger audit fee premium
T2 - Evidence from China
AU - Cheng, Zijian
AU - Liu, Zhangxin (Frank)
AU - Wang, Isabel Zhe
AU - Zhao, Xingju
N1 - Publisher Copyright:
© 2023
PY - 2024/7
Y1 - 2024/7
N2 - We examine the impact of listing via a reverse merger (RM) on audit fees, which can serve as an indicator of a firm's perceived risk. Using a manually assembled dataset of Chinese companies from 2010 to 2019, we find that RMs tend to pay higher audit fees than their counterparts who undertake an initial public offering (IPO), primarily due to the increased risk of corporate litigation and financial misstatement. Furthermore, RMs with performance commitments are subject to even higher fees, and this audit fee premium is particularly evident during the performance commitment period. Our analysis shows that the audit fee premium for RMs is lower in state-owned enterprises, firms with robust internal control, and those operating under weaker oversight. These findings highlight the perceived risks associated with RMs in China and offer insights into why RMs frequently underperform following their listing in the Chinese market
AB - We examine the impact of listing via a reverse merger (RM) on audit fees, which can serve as an indicator of a firm's perceived risk. Using a manually assembled dataset of Chinese companies from 2010 to 2019, we find that RMs tend to pay higher audit fees than their counterparts who undertake an initial public offering (IPO), primarily due to the increased risk of corporate litigation and financial misstatement. Furthermore, RMs with performance commitments are subject to even higher fees, and this audit fee premium is particularly evident during the performance commitment period. Our analysis shows that the audit fee premium for RMs is lower in state-owned enterprises, firms with robust internal control, and those operating under weaker oversight. These findings highlight the perceived risks associated with RMs in China and offer insights into why RMs frequently underperform following their listing in the Chinese market
KW - Audit fee
KW - IPOs
KW - Performance commitment
KW - Reverse mergers
UR - http://www.scopus.com/inward/record.url?scp=85190975293&partnerID=8YFLogxK
U2 - 10.1016/j.irfa.2024.103318
DO - 10.1016/j.irfa.2024.103318
M3 - Article
SN - 1057-5219
VL - 94
JO - International Review of Financial Analysis
JF - International Review of Financial Analysis
M1 - 103318
ER -